North America Autoimmune Disease Therapeutics Market By Indication (Rheumatic Disease, Diabetes, Multiple Sclerosis, Inflammatory Bowel Disease, and Other Indications) By Drug Class (Anti-Inflammatory, Anti-Hyperglycemics, NSAIDs Nonsteroidal anti-inflammatory drugs, Interferons and Other Drugs) By the Distribution Channel (Hospital Pharmacy, Online and Retail Pharmacies & Drug Stores)

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Autoimmune Disease Therapeutics Market, by Indication
1.4.2 North America Autoimmune Disease Therapeutics Market, by Drug Class
1.4.3 North America Autoimmune Disease Therapeutics Market, by Distribution Channel
1.4.4 North America Autoimmune Disease Therapeutics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Autoimmune Disease Therapeutics Market by Indication
3.1 North America Rheumatic Disease Market by Country
3.2 North America Diabetes Market by Country
3.3 North America Multiple Sclerosis Market by Country
3.4 North America Inflammatory Bowel Disease Market by Country
3.5 North America Other Indications Market by Country
Chapter 4. North America Autoimmune Disease Therapeutics Market by Drug Class
4.1 North America Anti-Inflammatory Market by Country
4.2 North America Anti-Hyperglycemics Market by Country
4.3 North America NSAIDs Market by Country
4.4 North America Interferons Market by Country
4.5 North America Other Drugs Market by Country
Chapter 5. North America Autoimmune Disease Therapeutics Market by Distribution Channel
5.1 North America Hospital Pharmacy Market by Country
5.2 North America Online Market by Country
5.3 North America Retail Pharmacies and Drug Stores Market by Country
Chapter 6. North America Autoimmune Disease Therapeutics Market by Country
6.1 USA Autoimmune Disease Therapeutics Market
6.1.1 USA Autoimmune Disease Therapeutics Market by Indication
6.1.2 USA Autoimmune Disease Therapeutics Market by Drug Class
6.1.3 USA Autoimmune Disease Therapeutics Market by Distribution Channel
6.2 Canada Autoimmune Disease Therapeutics Market
6.2.1 Canada Autoimmune Disease Therapeutics Market by Indication
6.2.2 Canada Autoimmune Disease Therapeutics Market by Drug Class
6.2.3 Canada Autoimmune Disease Therapeutics Market by Distribution Channel
6.3 Mexico Autoimmune Disease Therapeutics Market
6.3.1 Mexico Autoimmune Disease Therapeutics Market by Indication
6.3.2 Mexico Autoimmune Disease Therapeutics Market by Drug Class
6.3.3 Mexico Autoimmune Disease Therapeutics Market by Distribution Channel
6.4 Rest of North America Autoimmune Disease Therapeutics Market
6.4.1 Rest of North America Autoimmune Disease Therapeutics Market by Indication
6.4.2 Rest of North America Autoimmune Disease Therapeutics Market by Drug Class
6.4.3 Rest of North America Autoimmune Disease Therapeutics Market by Distribution Channel
Chapter 7. Company Profiles
7.1 ABBOTT Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.2 Bio-Rad Laboratories, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.3 Johnson and Johnson
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental &Regional Analysis
7.3.4 Research & Development Expenses
7.3.1 Recent strategies and developments:
7.3.1.1 Collaborations, partnerships and agreements:
7.4 GlaxoSmithKline PLC (GSK)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and mergers:
7.4.5.2 Collaborations, partnerships and agreements:
7.4.5.3 Product launches:
7.5 Pfizer, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Collaborations, partnerships and agreements:
7.5.5.2 Approval:
7.6 Merck & Co., Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Collaborations, partnerships and agreements:
7.6.5.2 Acquisition and mergers:
7.7 Bayer AG (Bayer Schering Pharma AG)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Collaborations, partnerships and agreements:
7.8 AbbVie, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Collaborations, partnerships and agreements:
7.9 Amgen, Inc.
7.9.1 Company overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Product launches:
7.9.5.2 Collaborations, partnerships and agreements:
7.1 Novartis AG
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Acquisition and mergers:
7.10.5.2 Collaborations, partnerships and agreements: